LT3001 Drug Product

LT3001 · Lumosa Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LT3001 Drug Product, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT [Phase 2]